GHDX
Genomic Health, Inc.
GHDX
GHDX
Delisted
GHDX was delisted on the 7th of November, 2019.
112 hedge funds and large institutions have $901M invested in Genomic Health, Inc. in 2015 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 44 increasing their positions, 30 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
6% less capital invested
Capital invested by funds: $963M → $901M (-$61.7M)
80% less call options, than puts
Call options by funds: $2.16M | Put options by funds: $11M
Holders
112
Holding in Top 10
2
Calls
$2.16M
Puts
$11M
Top Buyers
| 1 | +$4.92M | |
| 2 | +$3.11M | |
| 3 | +$3.1M | |
| 4 |
BC
Broadfin Capital
New York
|
+$2.29M |
| 5 |
JPMorgan Chase & Co
New York
|
+$1.6M |
Top Sellers
| 1 | -$15M | |
| 2 | -$9.22M | |
| 3 | -$6.4M | |
| 4 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
-$2.55M |
| 5 |
ICM
IronBridge Capital Management
Oakbrook Terrace,
Illinois
|
-$2.03M |